editorials · reviews · multicenter studies · meta-analyses · randomized controlled trials · retractions
Prescrire international · Feb 2009
In type 2 diabetes, sitagliptin, in combination with a sulphonylurea, only provides modest efficacy in terms of HbA1c levels and increases the risk of hypoglycaemia.
read on… or not…
read more… or not…
We guarantee your privacy. Your email address will not be shared.
Receive a weekly email with the highest quality and most significant abstracts from critical care specialties.
Anesthesiology, Critical Care Medicine, Emergency Medicine, Medicine, and Pain medicine.
Includes a free 21 day trial of metajournal premium
We guarantee your privacy. Your email address will not be shared. Unsubscribe anytime.